SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11752903
Source:
http://linkedlifedata.com/resource/pubmed/id/11752903
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026626
,
umls-concept:C0026809
,
umls-concept:C0042769
,
umls-concept:C0052278
,
umls-concept:C0149256
,
umls-concept:C1280500
pubmed:issue
2
pubmed:dateCreated
2001-12-25
pubmed:abstractText
To investigate the effects of Z-100, an arabinomannan extracted from Mycobacterium tuberculosis, on the LP-BM5 murine leukemia virus (LP-BM5 MuLV) infection in mice.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007504
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10
,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids
,
http://linkedlifedata.com/resource/pubmed/chemical/Mannans
,
http://linkedlifedata.com/resource/pubmed/chemical/specific substance maruyama
pubmed:status
MEDLINE
pubmed:issn
1015-2008
pubmed:author
pubmed-author:KobayashiMM
,
pubmed-author:PollardR BRB
,
pubmed-author:SasakiHH
,
pubmed-author:SuzukiFF
pubmed:copyrightInfo
Copyright 2001 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
96-103
pubmed:dateRevised
2006-7-27
pubmed:meshHeading
pubmed-meshheading:11752903-Animals
,
pubmed-meshheading:11752903-Anti-HIV Agents
,
pubmed-meshheading:11752903-Drug Antagonism
,
pubmed-meshheading:11752903-Interleukin-10
,
pubmed-meshheading:11752903-Interleukin-4
,
pubmed-meshheading:11752903-Leukemia Virus, Murine
,
pubmed-meshheading:11752903-Lipids
,
pubmed-meshheading:11752903-Lymphatic Diseases
,
pubmed-meshheading:11752903-Male
,
pubmed-meshheading:11752903-Mannans
,
pubmed-meshheading:11752903-Mice
,
pubmed-meshheading:11752903-Mice, Inbred C57BL
,
pubmed-meshheading:11752903-Murine Acquired Immunodeficiency Syndrome
,
pubmed-meshheading:11752903-Organ Size
,
pubmed-meshheading:11752903-Specific Pathogen-Free Organisms
,
pubmed-meshheading:11752903-Spleen
,
pubmed-meshheading:11752903-Splenomegaly
,
pubmed-meshheading:11752903-Survival Rate
,
pubmed-meshheading:11752903-T-Lymphocytes
pubmed:year
2001
pubmed:articleTitle
Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice.
pubmed:affiliation
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555-0435, USA.
pubmed:publicationType
Journal Article